Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

DermTech

NASDAQ DMTK
$0.63 -0.0004 -0.06%
Today share price
USA
Sector: Industry:
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

21.59M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-12.06M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.91
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
34.33M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-64.06 %

Upcoming events DermTech

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart DermTech

Stock analysis DermTech

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.22 -0.57
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.38 1.11
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.12 0.12
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.34 0.34
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-175.10 -18.24

Price change DermTech per year

11.02$ 84.49$
Min Max

Summary analysis DermTech

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure DermTech

Revenue and net income DermTech

All parameters

Stock news DermTech

All news
1 February в 01:05

DermTech to Cut Workforce by 15%, Six Months After Round of Layoffs

1 February в 01:05

DermTech to Cut Workforce by 15%, Six Months After Round of Layoffs

8 January в 19:05

DermTech Shares Rise 14% After Positive Results in Melanoma Test Study

8 January в 19:05

DermTech Shares Rise 14% After Positive Results in Melanoma Test Study

19 July 2023 в 18:45

DermTech Shares Rise 15% After New Michigan Coverage

19 July 2023 в 18:40

DermTech Shares Rise 15% After New Michigan Coverage

29 June 2023 в 00:50

DermTech Shares Surge on Plans to Cut Workforce, Reduce Annual Expenses

29 June 2023 в 00:50

DermTech Shares Surge on Plans to Cut Workforce, Reduce Annual Expenses

29 June 2023 в 00:15

DermTech to Cut Workforce, Reduce Annual Expenses by Up to $30M

29 June 2023 в 00:10

DermTech to Cut Workforce, Reduce Annual Expenses by Up to $30M

26 April 2023 в 15:30

DermTech Gets Contract From New York Health Plan

26 April 2023 в 15:30

DermTech Gets Contract From New York Health Plan

23 January 2023 в 18:05

DermTech Shares Rise 14% After Two New Coverage Policies

23 January 2023 в 18:00

DermTech Shares Rise 14% After Two New Coverage Policies

10 January 2023 в 21:25

DermTech Shares Gain 38% on Tricare Coverage Recommendation

10 January 2023 в 21:25

DermTech Shares Gain 38% on Tricare Coverage Recommendation

9 August 2022 в 18:36

DermTech Shares Plunge 30% On Lowered FY22 Revenue Outlook

9 August 2022 в 18:31

DermTech Shares Plunge 30% On Lowered FY22 Revenue Outlook

About company DermTech

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Address:
11099 North Torrey Pines Road, La Jolla, CA, United States, 92037
Company name: DermTech
Issuer ticker: DMTK
ISIN: US24984K1051
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-08-10
Site: https://www.dermtech.com

On which stock exchange are DermTech (DMTK) stocks traded?

DermTech (DMTK) stocks are traded on NASDAQ.

What is the ticker of DermTech stocks (DMTK)?

The stock ticker of DermTech’s stocks or in other words, the code is DMTK. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does DermTech (DMTK) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, DermTech (DMTK) belongs to the «» sector and the «» industry.

In what currency are DermTech (DMTK) stocks traded?

DermTech (DMTK) stocks are traded on the NASDAQ exchange in dollars.

What is the price of DermTech (DMTK) stocks today?

The current price of DermTech stocks on 05.05.2024 is 0.629 dollars. per share.

What is the dynamics of DermTech (DMTK) stocks from the beginning of the year?

DermTech (DMTK) quotes have increased by -62.11% from the beginning of the year up to 0.629 dollars. per 1 stocks.

How much did DermTech (DMTK) stocks increase in мае 2024?

This month DermTech (DMTK) quotes have increased by 1.94% to 0.629 dollars. per share.

How much are DermTech (DMTK) stocks worth?

Today, on October, 05.05.2024 DermTech’s (DMTK) stocks cost 0.629 dollars..

What is the market capitalization of DermTech (DMTK)?

Capitalization is the market value of DermTech (DMTK) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of DermTech (DMTK) is estimated at about 21591455 dollars.